Lab Reagents
Human IgG antibody Laboratories manufactures the anti mouse pd1 antibody reagents distributed by Genprice. The Anti Mouse Pd1 Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact mouse Antibody. Other Anti products are available in stock. Specificity: Anti Category: Mouse Group: Pd1 Antibody
Pd1 Antibody information
PD1 Conjugated Antibody |
C45030 |
SAB |
100ul |
EUR 476.4 |
PD1 Blocking Antibody |
48361-100ul |
SAB |
100ul |
EUR 399.6 |
PD1 Blocking Antibody |
48361-50ul |
SAB |
50ul |
EUR 286.8 |
PD1 antibody (FITC) |
61R-1186 |
Fitzgerald |
100 ug |
EUR 418.8 |
Description: Rat monoclonal PD1 antibody (FITC) |
PD1 antibody (FITC) |
61R-1189 |
Fitzgerald |
100 ug |
EUR 418.8 |
Description: Armenian Hamster monoclonal PD1 antibody (FITC) |
PD1 antibody (PE) |
61R-1443 |
Fitzgerald |
100 ug |
EUR 463.2 |
Description: Rat monoclonal PD1 antibody (PE) |
PD1 antibody (PE) |
61R-1444 |
Fitzgerald |
100 ug |
EUR 463.2 |
Description: Armenian Hamster monoclonal PD1 antibody (PE) |
PD1 antibody (biotin) |
61R-1692 |
Fitzgerald |
100 ug |
EUR 360 |
Description: Rat monoclonal PD1 antibody (biotin) |
PD1 antibody (biotin) |
61R-1694 |
Fitzgerald |
100 ug |
EUR 360 |
Description: Armenian Hamster monoclonal PD1 antibody (biotin) |
PD1 Antibody [4D6] |
RF16001-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [4D6] |
RF16001-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [8A4] |
RF16002-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [8A4] |
RF16002-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [7H6] |
RF16003-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [7H6] |
RF16003-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [4C7] |
RF16004-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [4C7] |
RF16004-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |